{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/albemarle-alb/",
 "dataUrl": "https://clearank.com/stock/albemarle-alb/data.json",
 "title": "Albemarle (ALB) Stock Forecast & Price Target (2026)",
 "description": "ALB stock forecast and price target 2026: is Albemarle a buy? Beat EPS estimates in 6 of 8 reports. A US specialty chemicals stock on the NYSE.",
 "headline": "Albemarle Corporation (ALB)",
 "published": "2026-11-09T18:55:44+00:00",
 "modified": "2026-11-09T18:55:45.258+00:00",
 "generated": "2026-11-11T13:24:40.436Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by Michelle Sofia, Market Analyst; prices delayed by up to a minute.",
 "asset": {
  "ticker": "ALB",
  "name": "Albemarle Corporation",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Basic Materials",
  "industry": "Specialty Chemicals",
  "country": "United States",
  "website": "https://www.albemarle.com"
 },
 "quote": {
  "price": 94.93,
  "previousClose": 99.12,
  "change": -4.19,
  "changePercent": -4.23,
  "open": 96.7,
  "high": 97.18,
  "low": 93.93,
  "volume": 1954262,
  "averageVolume": 2988686,
  "marketCap": 11202674965,
  "fiftyTwoWeekHigh": 221,
  "fiftyTwoWeekLow": 89.77,
  "marketOpen": false,
  "asOf": "2026-11-10T23:53:40.000Z"
 },
 "statistics": {
  "pe": 22.87,
  "eps": 4.15,
  "dividendYield": 0.017117876329927315,
  "beta": 1.358,
  "priceToSales": 1.8206,
  "priceToBook": 1.4054242,
  "revenueTtm": 6153171968,
  "grossMargin": 0.33860872947084086,
  "returnOnEquity": 0.07047
 },
 "technicals": {
  "rsi": 43.1,
  "macd": -2.51,
  "sma50": 105.98,
  "sma200": 147.03,
  "rsiSignal": "Neutral",
  "trend": "Bearish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Hold",
  "score": 52,
  "consensus": "Hold",
  "fairValue": null,
  "analystTarget": 135,
  "analystCount": 23,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-11-10T23:53:40.000Z",
  "priceAtAnalysis": 94.93,
  "volatility": {
   "daily": 2.34,
   "risk": "standard"
  }
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 52.79,
    "base": 98.92,
    "upside90th": 185.36
   },
   {
    "year": 2028,
    "downside10th": 42.41,
    "base": 103.08,
    "upside90th": 250.54
   },
   {
    "year": 2029,
    "downside10th": 36.19,
    "base": 107.41,
    "upside90th": 318.74
   },
   {
    "year": 2030,
    "downside10th": 31.87,
    "base": 111.92,
    "upside90th": 393
   }
  ]
 },
 "faqCount": 6,
 "atAGlance": {
  "asOf": "November 10, 2026",
  "rating": "Hold",
  "score": 52,
  "evidence": [
   {
    "label": "Trend",
    "text": "Down: the price is below both its 50- and 200-day moving averages ($105.98 and $147.03)."
   },
   {
    "label": "Earnings",
    "text": "ALB beat estimates in 6 of its last 8 quarters, yet fell in the first session after 2 of those beats."
   },
   {
    "label": "Insiders",
    "text": "Insiders sold $7.4M and bought $18K over the last 18 months."
   },
   {
    "label": "Valuation",
    "text": "P/E of 22.9 against 30.2 for the Basic Materials sector: a discount to peers (-24%)."
   }
  ]
 },
 "figures": {
  "asOf": "November 10, 2026",
  "earningsReaction": {
   "quarters": 8,
   "beats": 6,
   "fellFirstSessionAfterBeat": 2,
   "latestReport": "Nov 4, 2026",
   "latestSurprisePercent": 1.98,
   "latestFirstSessionMovePercent": 3.58
  },
  "insiders": {
   "windowMonths": 18,
   "soldValue": 7379279,
   "boughtValue": 17869,
   "sales": 6,
   "purchases": 1,
   "note": "open-market transactions only; grants and option exercises excluded"
  },
  "drawdown": {
   "years": 10,
   "worstFallPercent": -82.2,
   "peak": "September 2022",
   "trough": "April 2025",
   "recoveredBy": null,
   "recoveryMonths": null,
   "belowThatPeakNowPercent": -67.31,
   "fromHighNowPercent": -67.31,
   "oneYearHoldsPositivePercent": 48,
   "dividendsReinvested": true
  },
  "seasonality": {
   "years": 10,
   "bestMonth": {
    "month": "Nov",
    "averagePercent": 9.61,
    "upYearsPercent": 78
   },
   "worstMonth": {
    "month": "Mar",
    "averagePercent": -5.25,
    "upYearsPercent": 20
   }
  },
  "correlations": null,
  "analystTargets": {
   "analysts": 23,
   "low": 83.28,
   "median": 135,
   "high": 211,
   "mean": 142.35,
   "buy": 14,
   "hold": 9,
   "sell": 0
  },
  "dividend": {
   "yieldPercent": 1.71,
   "annualPerShare": 1.63
  },
  "simulation": {
   "year": 2030,
   "base": 111.92,
   "percentile10": 31.87,
   "percentile90": 393,
   "note": "Monte Carlo simulation outcomes, not price targets"
  }
 },
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "ch-overview",
   "title": "ALB stock today, November 11, 2026: price, news and analyst targets",
   "text": [
    "As of November 10, 2026, Albemarle Corporation (ALB) trades at $94.93. Wall Street's median 12-month price target is $135.00 across 23 analysts, 42.2% above the price. CleaRank rates it Hold with a score of 52/100.",
    "Albemarle's stock is trading near the bottom of its 52-week range after a steep slide over the past six months, even as its operating results have improved. The shares closed at $94.93, down 4.23% in the last session, and sit 5.75% above the 52-week low of $89.77. The stock is still well below its 50-day and 200-day moving averages ($105.98 and $147.03), so the trend remains down. The question for investors is whether earnings strength and analyst support can outweigh a price that has not yet recovered its footing.",
    "Albemarle's results have been running ahead of expectations. Adjusted EPS of $2.58 in the November 4, 2026 report beat the $2.53 estimate by 1.98%, and the stock rose 3.58% in the following session. The August 5, 2026 report was stronger, with $3.75 against $3.24, a 15.74% beat, and the shares rose 5.54% after it. The May 6, 2026 report beat by 125.19%, though that was against a low estimate of $1.31. Over the eight reports on record, six beat estimates. Yet the share price still fell 26.62% over three months and 53.81% over six months. The market appears to be discounting the earnings outlook rather than the current quarter's results.",
    "On trailing earnings, the stock trades at 22.87 times, a discount to the sector median P/E of 30.2. The price-to-sales ratio of 1.82 is 56.7% below the sector median of 4.2. Trailing GAAP EPS is $4.15, and the company's market capitalisation is $11.2B. The discount reflects the weak profitability: return on equity is 7.05% against a sector median of 17.9%, and the net profit margin is 8.4%. The balance sheet is conservative, with debt-to-equity at 0.18, and the company is rated 3 of 5 for health.",
    "Revenue grew 18.80% in the latest quarter year on year, slightly below the sector median of 19.0%. Analysts expect revenue to grow 17.6% this fiscal year to about $6.0B, but they forecast earnings per share to shrink 17.6% next year. That split between top-line growth and falling earnings is central to the debate. The stock's beta of 1.36 means it has moved more than the broader market, and its typical daily move is 2.34%.",
    "Over the last 18 months, insiders sold $7.4M of stock across six sales and bought $18K in one open-market purchase. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less signal than open-market buying. The small purchase is the only insider transaction that was made in the market rather than tied to compensation.",
    "CleaRank score 52/100 (Hold). 9 of 19 checks pass: trend 0 of 4, momentum 1 of 3, valuation and quality 5 of 5, analysts 3 of 3, track record 0 of 4.",
    "Albemarle Corporation is a global specialty chemicals company focused on lithium, bromine, and catalyst solutions. Albemarle supplies critical materials used in energy storage, electric mobility, electronics, construction, agriculture, pharmaceuticals, and petroleum refining. Its lithium products support battery supply chains for grid storage and transportation, while its bromine specialties serve flame retardants and other industrial applications. The company’s catalysts business provides technologies used in refining and chemical processing, helping customers improve product performance and operational efficiency."
   ]
  },
  {
   "id": "ch-news",
   "title": "ALB stock news",
   "text": [
    "Earnings report, November 4, 2026",
    "The November 4, 2026 report beat the EPS estimate by 1.98%, and the share price rose 3.58% in the first session after it.",
    "Analyst action, Truist Securities, November 6, 2026",
    "Truist Securities kept its Buy rating on November 6, 2026."
   ],
   "lists": {
    "items": [
     "Earnings beat Earnings report, November 4, 2026 The November 4, 2026 report beat the EPS estimate by 1.98%, and the share price rose 3.58% in the first session after it.",
     "Rating reaffirmed Analyst action, Truist Securities, November 6, 2026 Truist Securities kept its Buy rating on November 6, 2026."
    ]
   }
  },
  {
   "id": "ch-street",
   "title": "ALB price target 2026",
   "text": [
    "The base case for the coming months is that ALB stays volatile and range-bound while it works back toward its moving averages. Its last two reports beat estimates, and the shares rose the session after each, which suggests the earnings trend is intact. Analysts remain constructive: 14 of 23 rate the stock Buy or Strong Buy, none rate it Sell, and the median 12-month target is $135.00, well above the current price. Two conditions would support that view: a reclaim of the 20-day EMA at $96.98 and then the 50-day SMA at $105.98, with revenue growth holding near its recent pace. A close below the 52-week low of $89.77 would weaken the case and bring the lower analyst targets, such as $83.28, into position. Analysts expect earnings per share to shrink next year, from $10.56 this year to $8.70 in 2027, so that forecast is a key risk to the bullish targets."
   ],
   "tables": [
    {
     "caption": "Recent analyst rating actions on ALB",
     "columns": [
      "Date",
      "Firm",
      "Action",
      "Rating"
     ],
     "rows": [
      {
       "label": "Nov 6, 2026",
       "cells": [
        "Truist Securities",
        "Reiterates",
        "Buy"
       ]
      },
      {
       "label": "Nov 6, 2026",
       "cells": [
        "RBC Capital",
        "Maintains",
        "Outperform"
       ]
      },
      {
       "label": "Nov 6, 2026",
       "cells": [
        "Barclays",
        "Maintains",
        "Equal-Weight"
       ]
      },
      {
       "label": "Oct 22, 2026",
       "cells": [
        "Citigroup",
        "Maintains",
        "Buy"
       ]
      },
      {
       "label": "Oct 20, 2026",
       "cells": [
        "Truist Securities",
        "Maintains",
        "Buy"
       ]
      },
      {
       "label": "Oct 15, 2026",
       "cells": [
        "RBC Capital",
        "Maintains",
        "Outperform"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-levels",
   "title": "ALB support and resistance levels",
   "text": [
    "Support sits at the 52-week low of $89.77, the nearest level below the price and the line where a fall would meet first. A break there would open the door to lower levels further down. Resistance comes first at the 20-day exponential moving average of $96.98, which a rise would meet first, followed by the 50-day simple moving average of $105.98, which has been the level the stock has traded below since its recent decline."
   ],
   "tables": [
    {
     "caption": "ALB support and resistance levels",
     "columns": [
      "Level",
      "What it is",
      "Price",
      "From the price"
     ],
     "rows": [
      {
       "label": "Resistance 4",
       "cells": [
        "52-week high",
        "$221.00",
        "+132.8%"
       ]
      },
      {
       "label": "Resistance 3",
       "cells": [
        "200-day moving average",
        "$147.03",
        "+54.9%"
       ]
      },
      {
       "label": "Resistance 2",
       "cells": [
        "50-day moving average",
        "$105.98",
        "+11.6%"
       ]
      },
      {
       "label": "Resistance 1",
       "cells": [
        "20-day exponential average",
        "$96.98",
        "+2.2%"
       ]
      },
      {
       "label": "Price",
       "cells": [
        "November 10, 2026",
        "$94.93",
        ""
       ]
      },
      {
       "label": "Support 1",
       "cells": [
        "52-week low",
        "$89.77",
        "-5.4%"
       ]
      }
     ]
    }
   ],
   "lists": {
    "items": [
     "RSI Neutral",
     "SMA cross Bearish",
     "Price vs SMA Bearish",
     "MACD Bearish"
    ]
   }
  },
  {
   "id": "ch-price",
   "title": "ALB stock price and trading"
  },
  {
   "id": "ch-fundamentals",
   "title": "ALB fundamentals and valuation",
   "text": [
    "Price to earnings vs sector: ALB trades at a notable discount to sector peers (-24% against the sector median P/E). Investors are paying less for each dollar of earnings than for the typical stock in the sector.",
    "Return vs XLB: Since May 30, 2025, ALB has gained 70.3% against a gain of 22.4% for XLB.",
    "Revenue growth: Revenue fell 4.4% in FY2025 to $5.1B, from $5.4B a year earlier.",
    "Profit margin: The net margin was -9.0% in FY2025, up from -21.1% the year before.",
    "Loss-making: ALB lost $465M in FY2025.",
    "Earnings record: ALB beat the analyst estimate in 6 of the last 8 quarters.",
    "Market reaction: The stock fell in the first session after 2 of those 6 beats, so a beat has not been enough on its own."
   ],
   "tables": [
    {
     "caption": "ALB earnings surprises and the stock's reaction",
     "columns": [
      "Report",
      "Estimate",
      "Actual",
      "Surprise",
      "First sessionDay 1",
      "5 sessionsDay 5"
     ],
     "rows": [
      {
       "label": "Nov 4, 2026",
       "cells": [
        "$2.53",
        "$2.58",
        "+1.98%",
        "+3.58%",
        "-"
       ]
      },
      {
       "label": "Aug 5, 2026",
       "cells": [
        "$3.24",
        "$3.75",
        "+15.74%",
        "+5.54%",
        "+7.99%"
       ]
      },
      {
       "label": "May 6, 2026",
       "cells": [
        "$1.31",
        "$2.95",
        "+125.19%",
        "+2.98%",
        "+4.32%"
       ]
      },
      {
       "label": "Feb 11, 2026",
       "cells": [
        "-$0.49",
        "-$0.53",
        "-8.16%",
        "-9.41%",
        "-4.00%"
       ]
      },
      {
       "label": "Nov 5, 2025",
       "cells": [
        "-$0.88",
        "-$0.19",
        "+78.41%",
        "-0.76%",
        "+19.97%"
       ]
      },
      {
       "label": "Jul 30, 2025",
       "cells": [
        "-$0.81",
        "$0.11",
        "+113.58%",
        "-1.51%",
        "-2.31%"
       ]
      },
      {
       "label": "Apr 30, 2025",
       "cells": [
        "-$0.68",
        "-$0.18",
        "+73.53%",
        "+1.32%",
        "-4.25%"
       ]
      },
      {
       "label": "Feb 12, 2025",
       "cells": [
        "-$0.67",
        "-$1.09",
        "-62.69%",
        "+3.46%",
        "+7.72%"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-history",
   "title": "ALB price history and drawdowns",
   "text": [
    "Against the market: ALB trailed the S&P 500 over this period: $13,212 against $40,115.",
    "A $10,000 investment in ALB in December 2016 would be worth about $13,212 today with dividends reinvested, compared with about $40,115 for the same investment in the S&P 500 benchmark (also with dividends reinvested)."
   ]
  },
  {
   "id": "ch-scenarios",
   "title": "ALB stock price prediction 2030",
   "text": [
    "CleaRank's simulation projects a price near $112 for ALB by 2030 in the base case, from $94.93 today (1.2x over 4 years). The 10th-percentile path ends near $31.87. These are outcomes of a Monte Carlo simulation run on ALB's historical return distribution, not price targets, and they assume no dividends are reinvested."
   ],
   "tables": [
    {
     "caption": "ALB simulated price paths by year",
     "columns": [
      "Year",
      "10th percentile",
      "Base case",
      "90th percentile",
      "range base today"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$52.79",
        "$98.92",
        "$185",
        ""
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$42.41",
        "$103",
        "$251",
        ""
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$36.19",
        "$107",
        "$319",
        ""
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$31.87",
        "$112",
        "$393",
        ""
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-insiders",
   "title": "ALB insider trading",
   "text": [
    "Net insider selling: Insiders bought $18K on the open market and sold $7.4M."
   ],
   "tables": [
    {
     "caption": "Insider transactions in ALB",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Sep 14, 2026",
       "cells": [
        "Autumn M Gagarinas Officer",
        "Grant",
        "5.2K",
        "-"
       ]
      },
      {
       "label": "Sep 14, 2026",
       "cells": [
        "Mark Richard Mummert Chief Operating Officer",
        "Grant",
        "6.1K",
        "-"
       ]
      },
      {
       "label": "Sep 14, 2026",
       "cells": [
        "Eric S. Norris Officer",
        "Grant",
        "10.9K",
        "-"
       ]
      },
      {
       "label": "Sep 1, 2026",
       "cells": [
        "Max Hood Officer",
        "Grant",
        "1.5K",
        "-"
       ]
      },
      {
       "label": "Jul 21, 2026",
       "cells": [
        "Bartolomeo Eduardo Desalles Director",
        "Grant",
        "1.4K",
        "-"
       ]
      },
      {
       "label": "Jul 1, 2026",
       "cells": [
        "Mary Laurie Brlas Director",
        "Grant",
        "1.3K",
        "-"
       ]
      },
      {
       "label": "Jul 1, 2026",
       "cells": [
        "Michelle T. Collins Director",
        "Grant",
        "1.3K",
        "-"
       ]
      },
      {
       "label": "Jul 1, 2026",
       "cells": [
        "Ralf Hans Cramer Director",
        "Grant",
        "1.3K",
        "-"
       ]
      },
      {
       "label": "Jul 1, 2026",
       "cells": [
        "Diarmuid O'Connell Director",
        "Grant",
        "1.3K",
        "-"
       ]
      },
      {
       "label": "Jul 1, 2026",
       "cells": [
        "Gerald A Steiner Director",
        "Grant",
        "1.3K",
        "-"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-faq",
   "title": "ALB stock forecast: questions people ask",
   "text": [
    "How these figures are computed, and where the data comes from: CleaRank methodology."
   ]
  },
  {
   "id": "ch-related",
   "title": "Compare ALB with similar assets",
   "links": [
    {
     "text": "AA Alcoa Corporation NYSE $39.98 -4.40%",
     "url": "https://clearank.com/stock/alcoa-aa/"
    },
    {
     "text": "ECL Ecolab Inc. NYSE $306.03 -0.23%",
     "url": "https://clearank.com/stock/ecolab-ecl/"
    },
    {
     "text": "FCX Freeport-McMoRan Inc. NYSE $60.31 -3.24%",
     "url": "https://clearank.com/stock/freeport-mcmoran-fcx/"
    },
    {
     "text": "SCCO Southern Copper Corporation NYSE $170.36 -3.22%",
     "url": "https://clearank.com/stock/scco-stock-analysis/"
    },
    {
     "text": "WWR Westwater Resources Inc. NYSE $0.4100 +0.00%",
     "url": "https://clearank.com/stock/wwr-westwater-resources/"
    },
    {
     "text": "STLD Steel Dynamics, Inc. NASDAQ $236.12 +3.76%",
     "url": "https://clearank.com/stock/steel-dynamics-stld/"
    },
    {
     "text": "HL Hecla Mining Company NYSE $14.29 -7.27%",
     "url": "https://clearank.com/stock/hecla-mining-hl/"
    },
    {
     "text": "ASPI ASP Isotopes Inc. NASDAQ $1.98 -7.48%",
     "url": "https://clearank.com/stock/aspi-asp-isotopes/"
    },
    {
     "text": "YUM vs QSR Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/yum-vs-qsr/"
    },
    {
     "text": "CSX vs NSC Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/csx-vs-nsc/"
    },
    {
     "text": "Invesco QQQ vs Vanguard S&P 500 (VOO) Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/qqq-vs-voo/"
    }
   ]
  }
 ],
 "faq": [
  {
   "question": "What is the ALB stock forecast?",
   "answer": "The analysts' median 12-month price target is $135.00, which is 42.2% above the current price, with a range from $83.28 to $211.00 across 23 analysts. The nearest level below the price is the 52-week low of $89.77. The nearest level above it is the 20-day exponential moving average of $96.98."
  },
  {
   "question": "What is the ALB price target?",
   "answer": "The median 12-month analyst target is $135.00, with the lowest at $83.28 and the highest at $211.00. The Wall Street consensus rating is Buy. The stock at $94.93 sits well below the median target, though it is near the low of that range."
  },
  {
   "question": "Is ALB a buy or sell today?",
   "answer": "Analysts rate the stock Buy on consensus, with 14 of 23 rating it buy or strong buy, 9 hold and none sell. CleaRank rates the stock Hold with a score of 52 out of 100. The price is 10.43% below its 50-day SMA and 35.44% below its 200-day SMA, and the trend is down against both averages."
  },
  {
   "question": "Why has Albemarle stock fallen so much?",
   "answer": "The shares are down 53.81% over six months and 26.62% over three months, even though the company has beaten EPS estimates in six of its last eight reports. The price fall is best read as the market pricing a weaker earnings outlook, with analysts expecting EPS to shrink 17.6% next year."
  },
  {
   "question": "How does ALB compare with its sector on valuation?",
   "answer": "The trailing P/E of 22.87 is 24.3% below the sector median of 30.2. The price-to-sales ratio of 1.82 is 56.7% below the sector median of 4.2. Return on equity of 7.05% is well below the sector median of 17.9%, which helps explain the discount."
  },
  {
   "question": "Does Albemarle pay a dividend?",
   "answer": "The annual dividend is $1.63 per share, a trailing yield of 1.71%. At the current price, that yield is what the stock offers income investors."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "AA",
    "name": "Alcoa Corporation NYSE",
    "price": "$39.98",
    "change": "-4.40%",
    "url": "https://clearank.com/stock/alcoa-aa/"
   },
   {
    "ticker": "ECL",
    "name": "Ecolab Inc. NYSE",
    "price": "$306.03",
    "change": "-0.23%",
    "url": "https://clearank.com/stock/ecolab-ecl/"
   },
   {
    "ticker": "FCX",
    "name": "Freeport-McMoRan Inc. NYSE",
    "price": "$60.31",
    "change": "-3.24%",
    "url": "https://clearank.com/stock/freeport-mcmoran-fcx/"
   },
   {
    "ticker": "SCCO",
    "name": "Southern Copper Corporation NYSE",
    "price": "$170.36",
    "change": "-3.22%",
    "url": "https://clearank.com/stock/scco-stock-analysis/"
   },
   {
    "ticker": "WWR",
    "name": "Westwater Resources Inc. NYSE",
    "price": "$0.4100",
    "change": "+0.00%",
    "url": "https://clearank.com/stock/wwr-westwater-resources/"
   },
   {
    "ticker": "STLD",
    "name": "Steel Dynamics, Inc. NASDAQ",
    "price": "$236.12",
    "change": "+3.76%",
    "url": "https://clearank.com/stock/steel-dynamics-stld/"
   },
   {
    "ticker": "HL",
    "name": "Hecla Mining Company NYSE",
    "price": "$14.29",
    "change": "-7.27%",
    "url": "https://clearank.com/stock/hecla-mining-hl/"
   },
   {
    "ticker": "ASPI",
    "name": "ASP Isotopes Inc. NASDAQ",
    "price": "$1.98",
    "change": "-7.48%",
    "url": "https://clearank.com/stock/aspi-asp-isotopes/"
   }
  ],
  "comparisons": [
   {
    "ticker": "YUM vs QSR Comparison",
    "name": "",
    "url": "https://clearank.com/compare/yum-vs-qsr/"
   },
   {
    "ticker": "CSX vs NSC Comparison",
    "name": "",
    "url": "https://clearank.com/compare/csx-vs-nsc/"
   },
   {
    "ticker": "Invesco QQQ vs Vanguard S&P 500 (VOO) Comparison",
    "name": "",
    "url": "https://clearank.com/compare/qqq-vs-voo/"
   }
  ],
  "Newly Tracked": [
   {
    "ticker": "LYB",
    "text": "LyondellBasell Industries N.V.",
    "url": "https://clearank.com/stock/lyondellbasell-lyb/"
   },
   {
    "ticker": "VALE",
    "text": "Vale S.A.",
    "url": "https://clearank.com/stock/vale-vale/"
   },
   {
    "ticker": "HL",
    "text": "Hecla Mining Company",
    "url": "https://clearank.com/stock/hecla-mining-hl/"
   },
   {
    "ticker": "CTVA",
    "text": "Corteva Inc.",
    "url": "https://clearank.com/stock/corteva-ctva/"
   },
   {
    "ticker": "RIG",
    "text": "Transocean Ltd.",
    "url": "https://clearank.com/stock/transocean-rig/"
   }
  ],
  "Top Movers (latest session)": [
   {
    "ticker": "LEGN",
    "text": "↓ 15.97%",
    "url": "https://clearank.com/stock/legend-biotech-legn/"
   },
   {
    "ticker": "PL",
    "text": "↑ 14.50%",
    "url": "https://clearank.com/stock/planet-labs-pl/"
   },
   {
    "ticker": "ZEC/USD",
    "text": "↓ 12.04%",
    "url": "https://clearank.com/crypto/zcash-zec-usd/"
   },
   {
    "ticker": "RKLB",
    "text": "↑ 10.91%",
    "url": "https://clearank.com/stock/rocket-lab-rklb/"
   },
   {
    "ticker": "TSEM",
    "text": "↑ 10.89%",
    "url": "https://clearank.com/stock/tower-semiconductor-tsem/"
   }
  ],
  "Also in Basic Materials": [
   {
    "ticker": "APD",
    "text": "Air Products and Chemicals Inc.",
    "url": "https://clearank.com/stock/apd-stock-analysis/"
   },
   {
    "ticker": "ASPI",
    "text": "ASP Isotopes",
    "url": "https://clearank.com/stock/aspi-asp-isotopes/"
   },
   {
    "ticker": "ECL",
    "text": "Ecolab Inc.",
    "url": "https://clearank.com/stock/ecolab-ecl/"
   },
   {
    "ticker": "LIN",
    "text": "Linde",
    "url": "https://clearank.com/stock/lin-stock-analysis/"
   },
   {
    "ticker": "LYB",
    "text": "LyondellBasell",
    "url": "https://clearank.com/stock/lyondellbasell-lyb/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": [
      "CleaRank Financial AI",
      "CleaRank (Clear Rank)"
     ],
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free, and so is the Free plan of its trading workbench; CleaRank is paid for by yearly Pro and Unlimited subscriptions to that workbench, which combines a trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. It uses no affiliate links and takes no payment from the brokers, prop firms or companies it rates or writes about.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@type": "Place",
      "@id": "https://clearank.com/#place",
      "address": {
       "@type": "PostalAddress",
       "streetAddress": "Beni Berman 2",
       "addressLocality": "Netanya",
       "addressRegion": "Center",
       "postalCode": "4249330",
       "addressCountry": "IL"
      }
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@type": "SoftwareApplication",
      "@id": "https://clearank.com/#app",
      "name": "CleaRank",
      "url": "https://clearank.com/"
     },
     "founder": {
      "@type": "Person",
      "@id": "https://clearank.com/writer/shaundavidb/#person",
      "name": "Shaun David",
      "url": "https://clearank.com/writer/shaundavidb/"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/og/mi/stock/albemarle-alb.png",
     "url": "https://clearank.com/og/mi/stock/albemarle-alb.png",
     "width": "1200",
     "height": "630",
     "caption": "Albemarle Corporation (ALB) analysis by CleaRank",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/albemarle-alb/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": 1,
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": 2,
       "item": {
        "@id": "https://clearank.com/stock/",
        "name": "Stocks"
       }
      },
      {
       "@type": "ListItem",
       "position": 3,
       "item": {
        "@id": "https://clearank.com/stock/albemarle-alb/",
        "name": "Albemarle Corporation (ALB)"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/albemarle-alb/#webpage",
     "url": "https://clearank.com/stock/albemarle-alb/",
     "name": "Albemarle (ALB) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-11-09T18:55:44+00:00",
     "dateModified": "2026-11-09T18:55:45+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/og/mi/stock/albemarle-alb.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/albemarle-alb/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/michelle-sofia/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/michelle-sofia/#person",
     "name": "Michelle Sofia",
     "jobTitle": "Market Analyst",
     "url": "https://clearank.com/writer/michelle-sofia/",
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/albemarle-alb/#richSnippet",
     "headline": "Albemarle (ALB) Stock Forecast & Price Target (2026)",
     "name": "Albemarle (ALB) Stock Forecast & Price Target (2026)",
     "description": "ALB stock forecast and price target 2026: is Albemarle a buy? Beat EPS estimates in 6 of 8 reports. A US specialty chemicals stock on the NYSE.",
     "datePublished": "2026-11-09T18:55:44+00:00",
     "dateModified": "2026-11-09T18:55:45+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/market-insights/methodology/",
     "about": {
      "@type": "Corporation",
      "name": "Albemarle Corporation",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "ALB"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NYSE"
       }
      ],
      "description": "Albemarle Corporation is a global specialty chemicals company focused on lithium, bromine, and catalyst solutions. Albemarle supplies critical materials used in energy storage, electric mobility, electronics, construction, agriculture, pharmaceuticals, and petroleum refining.",
      "tickerSymbol": "ALB",
      "sameAs": "https://www.albemarle.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/albemarle-alb/#webpage"
     },
     "image": {
      "@type": "ImageObject",
      "url": "https://clearank.com/og/mi/stock/albemarle-alb.png",
      "width": 1200,
      "height": 630
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/albemarle-alb/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is the ALB stock forecast?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The analysts' median 12-month price target is $135.00, which is 42.2% above the current price, with a range from $83.28 to $211.00 across 23 analysts. The nearest level below the price is the 52-week low of $89.77. The nearest level above it is the 20-day exponential moving average of $96.98."
     }
    },
    {
     "@type": "Question",
     "name": "What is the ALB price target?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The median 12-month analyst target is $135.00, with the lowest at $83.28 and the highest at $211.00. The Wall Street consensus rating is Buy. The stock at $94.93 sits well below the median target, though it is near the low of that range."
     }
    },
    {
     "@type": "Question",
     "name": "Is ALB a buy or sell today?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Analysts rate the stock Buy on consensus, with 14 of 23 rating it buy or strong buy, 9 hold and none sell. CleaRank rates the stock Hold with a score of 52 out of 100. The price is 10.43% below its 50-day SMA and 35.44% below its 200-day SMA, and the trend is down against both averages."
     }
    },
    {
     "@type": "Question",
     "name": "Why has Albemarle stock fallen so much?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The shares are down 53.81% over six months and 26.62% over three months, even though the company has beaten EPS estimates in six of its last eight reports. The price fall is best read as the market pricing a weaker earnings outlook, with analysts expecting EPS to shrink 17.6% next year."
     }
    },
    {
     "@type": "Question",
     "name": "How does ALB compare with its sector on valuation?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The trailing P/E of 22.87 is 24.3% below the sector median of 30.2. The price-to-sales ratio of 1.82 is 56.7% below the sector median of 4.2. Return on equity of 7.05% is well below the sector median of 17.9%, which helps explain the discount."
     }
    },
    {
     "@type": "Question",
     "name": "Does Albemarle pay a dividend?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The annual dividend is $1.63 per share, a trailing yield of 1.71%. At the current price, that yield is what the stock offers income investors."
     }
    }
   ]
  }
 ]
}